Rapid induction of apoptosis in B-cell lymphoma by functionally isolated human antibodies

International Journal of Cancer

Volumn 119, Issue 2, 2006, Pages 349-358

  Fransson, Johan ^a   Tornberg, Ulla Carin ^b   Borrebaeck, Carl A K ^a   Carlsson, Roland ^b   Frendéus, Björn ^b  

^a LUND UNIVERSITY   (Sweden)

^b BioInvent International AB   (Sweden)

Author keywords

Antibody library; Apoptosis; B lymphoma; Intercellular adhesion molecule 1; Phage display

Indexed keywords

B LYMPHOCYTE RECEPTOR; CELL SURFACE RECEPTOR; HLA DP ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN FV FRAGMENT; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY ISOLATION; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL; LYMPHOMA CELL; PHAGE DISPLAY; PRIORITY JOURNAL;

ANTIBODIES; APOPTOSIS; FLOW CYTOMETRY; HLA-DP ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN MU-CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOMA, B-CELL;

EID: 33745220111     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21829     Document Type: Article

References (57)

1. Brekke OH, Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2003;2: 52-62.
2. Weiner LM, Carter P. Tunable antibodies. Nat Biotechnol 2005;23: 556-7.
3. Griffiths AD, Malmqvist M, Marks JD, Bye JM, Embleton MJ, McCafferty J, Baier M, Holliger KP, Gorick BD, Hughes-Jones NC, Hoogenboom HR, Winter G. Human anti-self antibodies with high specificity from phage display libraries. EMBO J 1993;12:725-34.
4. Hoogenboom HR, de Bruine AP, Hufton SE, Hoet RM, Arends JW, Roovers RC. Antibody phage display technology and its applications. Immunotechnology 1998;4:1-20.
5. Huls GA, Heijnen IA, Cuomo ME, Koningsberger JC, Wiegman L, Boel E, van der Vuurst de Vries AR, Loyson SA, Helfrich W, van Berge Henegouwen GP, van Meijer M, de Kruif J, et al. A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments. Nat Biotechnol 1999;17:276-81.
6. Fransson J, Ek S, Ellmark P, Söderlind E, Borrebaeck CA, Furebring C. Profiling of internalizing tumor-associated antigens on breast and pancreatic cancer cells by reversed genomics. Cancer Lett 2004;208: 235-42.
7. Liu B, Conrad F, Cooperberg MR, Kirpotin DB, Marks JD. Mapping tumor epitope space by direct selection of single-chain Fv antibody libraries on prostate cancer cells. Cancer Res 2004;64:704-10.
8. Ridgway JBB, Ng E, Kern JA, Lee J, Brush J, Goddard A, Carter P. Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines. Cancer Res 1999;59:2718-23.
9. Popkov M, Rader C, Barbas CF, III. Isolation of human prostate cancer cell reactive antibodies using phage display technology. J Immunol Methods 2004;291:137-51.
10. Williams B, Atkins A, Zhang H, Lu D, Jimenez X, Li H, Wang MN, Ludwig D, Balderes P, Witte L, Li Y, Zhu Z. Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth. Leukemia 2005;19: 1432-8.
11. de Kruif J, Terstappen L, Boel E, Logtenberg T. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc Natl Acad Sci USA 1995;92: 3938-42.
12. Siegel DL, Chang TY, Russell SL, Bunya VY. Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: applications in immunohematology. J Immunol Methods 1997;206:73-85.
13. Cai X, Garen A. Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc Natl Acad Sci USA 1995;92:6537-41.
14. Poul MA, Becerril B, Nielsen UB, Morisson P, Marks JD. Selection of tumor-specific internalizing human antibodies from phage libraries. J Mol Biol 2000;301:1149-61.
15. Li J, Pereira S, Van Belle P, Tsui P, Elder D, Speicher D, Deen K, Linnenbach A, Somasundaram R, Swoboda R, Herlyn D. Isolation of the melanoma-associated antigen p23 using antibody phage display. J Immunol 2001;166:432-8.
16. Gao C, Mao S, Ronca F, Zhuang S, Quaranta V, Wirsching P, Janda KD. De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods. J Immunol Methods 2003;274:185-97.
17. Söderlind E, Strandberg L, Jirholt P, Kobayashi N, Alexeiva V, Aberg AM, Nilsson A, Jansson B, Ohlin M, Wingren C, Danielsson L, Carlsson R, et al. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol 2000;18:852-6.
18. Daibata M, Kubonishi I, Eguchi T, Yano S, Ohtsuki Y, Miyoshi I. The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14) (q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma. Cancer 1989;64:1248-53.
19. Saltman DL, Cachia PG, Dewar AE, Ross FM, Krajewski AS, Ludlam C, Steel CM. Characterization of a new non-Hodgkin's lymphoma cell line (NCEB-1) with a chromosomal (11:14) translocation [t(11:14)(q13;q32)]. Blood 1988;72:2026-30.
20. Menezes J, Leibold W, Klein G, Clements G. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 1975;22:276-84.
21. Cerutti A, Zan H, Schaffer A, Bergsagel L, Harindranath N, Max EE, Casali P. CD40 Ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol 1998;160:2145-57.
22. Hallborn J, Carlsson R. Automated screening procedure for high-throughput generation of antibody fragments. Biotechniques 2002; 33:30-7.
23. Norderhaug L, Olafsen T, Michaelsen TE, Sandlie I. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J Immunol Methods 1997;204:77-87.
24. Edvardsson U, Alexandersson M, Brockenhuus von Lowenhielm H, Nystrom AC, Ljung B, Nilsson F, Dahllof B. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY 14,643. Electrophoresis 1999;20:935-42.
25. Rosenthal HE. A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem 1967; 20:525-32.
26. Bylund DB, Yamamura HI. Methods for receptor binding. In: Yamamura HI, ed. Methods in neurotransmitter receptor analysis. New York: Raven Press, 1990.1-35.
27. Marquart DW. An algorithm for least squares estimation of non-linear parameters. J Soc Ind Appl Math 1963;11:431-41.
28. Brix K, Summa W, Lottspeich F, Herzog V. Extracellularly occurring histone H1 mediates the binding of thyroglobulin to the cell surface of mouse macrophages. J Clin Invest 1998;102:283-93.
29. Kim SG, Jong HS, Kim TY, Lee JW, Kim NK, Hong SH, Bang YJ. Transforming growth factor-β1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells. Mol Biol Cell 2004;15:420-34.
30. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987;51:813-9.
31. Rothlein R, Kishimoto TK, Mainolfi E. Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes. J Immunol 1994;152:2488-95.
32. Vyth-Dreese F, Dellemijn T, van Oostveen J, Feltkamp C, Hekman A. Functional expression of adhesion receptors and costimulatory molecules by fresh and immortalized B-cell non-Hodgkin's lymphoma cells. Blood 1995;85:2802-12.
33. Mandecki W, Chen YC, Grihalde N. A mathematical model for biopanning (affinity selection) using peptide libraries on filamentous phage. J Theor Biol 1995;176:523-30.
34. Stausbol-Gron B, Wind T, Kjaer S, Kahns L, Hansen NJ, Kristensen P, Clark BF. A model phage display subtraction method with potential for analysis of differential gene expression. FEBS Lett 1996;391:71-5.
35. Frendéus B. Screening methods. United Kingdom: The UK Patent Office, 2005.
36. Chaouchi N, Vazquez A, Galanaud P, Leprince C. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. J Immunol 1995;154: 3096-104.
37. Shan D, Ledbetter JA, Press OW. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 1998; 91:1644-52.
38. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995;13:437-57.
39. Wechsler-Reya RJ, Monroe JG. Lipopolysaccharide prevents apoptosis and induces responsiveness to antigen receptor cross-linking in immature B cells. Immunology 1996;89:356-62.
40. Yokochi T, Kato Y, Sugiyama T, Koide N, Morikawa A, Jiang GZ, Kawai M, Yoshida T, Fukada M, Takahashi K. Lipopolysaccharide induces apoptotic cell death of B memory cells and regulates B cell memory in antigen-nonspecific manner. FEMS Immunol Med Microbiol 1996;15:1-8.
41. Miller RA, Maloney DG, Warnke R, Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med 1982;306:517-22.
42. Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature 1988;332:323-7.
43. Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 1992;327:1209-15.
44. Suarez E, Yanez R, Barrios Y, Diaz-Espada F. Human monoclonal antibodies produced in transgenic BABkappa,lambda mice recognising idiotypic immunoglobulins of human lymphoma cells. Mol Immunol 2004;41:519-26.
45. Nagy ZA, Hubner B, Lohning C, Rauchenberger R, Reiffert S, Thomassen-Wolf E, Zahn S, Leyer S, Schier EM, Zahradnik A, Brunner C, Lobenwein K, et al. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nat Med 2002;8:801-7.
46. Nagy ZA, Mooney NA. A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules. J Mol Med 2003;81:757-65.
47. Tilghman RW, Hoover RL. E-selectin and ICAM-1 are incorporated into detergent-insoluble membrane domains following clustering in endothelial cells. FEBS Lett 2002;525:83-7.
48. Deans JP, Robbins SM, Polyak MJ, Savage JA. Rapid redistribution of CD20 to a low density detergent-insoluble membrane compartment. J Biol Chem 1998;273:344-8.
49. Smith ME, Thomas JA. Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. J Clin Pathol 1990;43:893-900.
50. Cosimi AB, Conti D, Delmonico FL, Preffer FI, Wee SL, Rothlein R, Faanes R, Colvin RB. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 1990;144:4604-12.
51. Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 1994;37:992-9.
52. Haug CE, Colvin RB, Delmonico FL, Auchincloss H, Jr, Tolkoff-Rubin N, Preffer FI, Rothlein R, Norris S, Scharschmidt L, Cosimi AB. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993;55: 766-72.
53. Uyttenhove C, Maryanski J, Boon T. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J Exp Med 1983;157: 1040-52.
54. Kennedy GA, Tey SK, Cobcroft R, Marlton P, Cull G, Grimmett K, Thomson D, Gill D. Incidence and nature of CD20-negative relapses following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: a retrospective review. Br J Haematol 2002;119:412-6.
55. Weiner GJ, Kaminski MS. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma. J Immunol 1989;142:343-51.
56. Bai X-F, Liu J, Li O, Zheng P, Liu Y. Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes. J Clin Invest 2003;111:1487-96.
57. Robert C, Soria JC, Spatz A, Le Cesne A, Malka D, Pautier P, Wechsler J, Lhomme C, Escudier B, Boige V, Armand JP, Le Chevalier T. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005;6:491-500.